NCT05182307View on ClinicalTrials.gov

DurAVR™ THV System: First-In-Human Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Symptomatic Aortic StenosisSevere Aortic Valve StenosisAortic Valve Calcification
Interventions
DEVICE

DurAVR™ THV System

Transcatheter Aortic Valve Implantation (TAVI) Procedure

Trial Locations (1)

Unknown

Tbilisi Heart and Vascular Clinic Ltd, Tbilisi

Sponsors
All Listed Sponsors
lead

Anteris Technologies Ltd.

INDUSTRY